Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis*
- Anne Quillet-Mary‡§,
- Jean-Pierre Jaffrézou‡,
- Véronique Mansat‡,
- Christine Bordier‡,
- Javier Naval¶ and
- Guy Laurent‡‖
- From the ‡CJF INSERM 9503, Centre Claudius Régaud, Toulouse Cedex, France, the ¶Department of Biochemistry and Molecular Biology, University of Zaragoza, 50009 Zaragoza, Spain, and the ‖CHU Purpan, Service d’Hématologie, Toulouse, France
Abstract
The key events implicated in ceramide-triggered apoptosis remain unknown. In this study we show that 25 μm C6-ceramide induced significant H2O2 production within 60 min, which increased up to 180 min in human myeloid leukemia U937 cells. Inactive analogue dihydro-C6-ceramide had no effect. Furthermore, no H2O2 production was observed in C6-ceramide-treated U937 ρ° cells, which are mitochondrial respiration-deficient. We also present evidence that ceramide-induced activation of the transcription factors NF-κB and AP-1 is mediated by mitochondrial derived reactive oxygen species. Both H2O2 production, transcription factor activation as well as apoptosis could be inhibited by rotenone and thenoyltrifluoroacetone (specific mitochondrial complexes I and II inhibitors) and antioxidants, N-acetylcysteine and pyrrolidine dithiocarbamate. These effects could be potentiated by antimycin A (specific complex III mitochondrial inhibitor). H2O2 production was also inhibitable by ruthenium red, suggesting a role of mitochondrial calcium homeostasis alterations in ceramide-induced oxidative stress. Finally, C6-ceramide had no influence on mitochondrial membrane potential within the first 6 h. Altogether, our study points to reactive oxygen species, generated at the ubiquinone site of the mitochondrial respiratory chain, as an early major mediator in ceramide-induced apoptosis.
Footnotes
-
↵* This work was supported in part by la Fédération Nationale des Centres de Lutte Contre le Cancer (A. Q. M., J. P. J.), le Conseil Régional Midi-Pyrénées (J. P. J.), l’Association pour la Recherche sur le Cancer Grants 6749 (G. L.) and 2069 (J. P. J.), and by La Ligue Nationale Contre le Cancer (G. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
↵§ To whom correspondence should be addressed: CJF INSERM 9503, Centre Claudius Régaud, 20–24 rue du Pont St Pierre, 31052 Toulouse Cedex, France. Tel.: 33 05 61 42 41 73; Fax: 33 05 61 42 46 06.
-
- Received August 15, 1996.
- Revision received April 15, 1997.











